A Q&A with Michael Foote, MD, MSK Gastrointestinal Medical Oncologist and member of the Peritoneal Surface Malignancies Consortium Group The Peritoneal Surface Malignancies Consortium Group (PSM ...
Gastric cancer remains a formidable adversary, ranking as the fifth most common cancer and the third-leading cause of cancer-related deaths worldwide, with over 1,000,000 new cases and close to ...
New study and promising results from the first clinical trial in patients provide novel insights and new hope for one of the deadliest of cancers. Gastric cancer remains a formidable adversary, ...
Metastatic colorectal adenocarcinoma (mCRC) with proficient mismatch repair (pMMR) is associated with poor response to cytotoxic chemotherapy in the refractory setting. In patients with peritoneal ...
High-Dose Chemotherapy and Autologous Peripheral-Blood Stem-Cell Transplantation for Relapsed Metastatic Germ Cell Tumors: The Indiana University Experience Eligibility criteria for patients from our ...
Malignant ascites can develop with late stage pancreatic cancer. Ascites involves the buildup of fluid in the abdomen. Doctors can drain the fluid to relieve symptoms, but fluid may return. Ascites ...
Neoantigen (tumor-specific antigen) mRNA-based vaccines induce progenitor‑exhausted T cells that support anti‑PD‑1 therapy, leading to enhanced antitumor efficacy against gastric cancer, which has ...
Image Caption: Proteomic alterations in post-NACT OCPM tissues. Genes & Diseases publishes rigorously peer-reviewed and high quality original articles and authoritative reviews that focus on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback